Mitsubishi UFJ Trust & Banking’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $86.8M | Buy |
174,812
+7,909
| +5% | +$3.51M | 0.19% | 113 |
|
|
2026
Q1 | $74.5M | Buy |
166,903
+4,697
| +3% | +$2.19M | 0.18% | 121 |
|
|
2025
Q4 | $73.5M | Buy |
162,206
+12,351
| +8% | +$5.32M | 0.17% | 117 |
|
|
2025
Q3 | $58.7M | Sell |
149,855
-498
| -0.3% | -$208K | 0.13% | 175 |
|
|
2025
Q2 | $66.9M | Sell |
150,353
-11,545
| -7% | -$5.32M | 0.16% | 148 |
|
|
2025
Q1 | $78.5M | Sell |
161,898
-9,708
| -6% | -$4.52M | 0.2% | 105 |
|
|
2024
Q4 | $69.1M | Sell |
171,606
-13,507
| -7% | -$6.26M | 0.16% | 133 |
|
|
2024
Q3 | $86.1M | Sell |
185,113
-5,015
| -3% | -$2.41M | 0.2% | 108 |
|
|
2024
Q2 | $89.1M | Sell |
190,128
-23,462
| -11% | -$10.2M | 0.21% | 100 |
|
|
2024
Q1 | $89.3M | Sell |
213,590
-16,028
| -7% | -$6.78M | 0.2% | 113 |
|
|
2023
Q4 | $93.4M | Buy |
229,618
+20,090
| +10% | +$7.42M | 0.22% | 111 |
|
|
2023
Q3 | $72.9M | Sell |
209,528
-7,080
| -3% | -$2.48M | 0.18% | 126 |
|
|
2023
Q2 | $76.2M | Sell |
216,608
-6,671
| -3% | -$2.25M | 0.18% | 131 |
|
|
2023
Q1 | $70.3M | Sell |
223,279
-11,693
| -5% | -$3.51M | 0.17% | 140 |
|
|
2022
Q4 | $67.9M | Sell |
234,972
-8,809
| -4% | -$2.68M | 0.18% | 137 |
|
|
2022
Q3 | $70.6M | Sell |
243,781
-34,409
| -12% | -$9.9M | 0.2% | 122 |
|
|
2022
Q2 | $78.4M | Buy |
278,190
+32,446
| +13% | +$8.68M | 0.2% | 118 |
|
|
2022
Q1 | $64.1M | Sell |
245,744
-9,025
| -4% | -$2.14M | 0.15% | 157 |
|
|
2021
Q4 | $55.9M | Sell |
254,769
-17,977
| -7% | -$3.5M | 0.12% | 199 |
|
|
2021
Q3 | $49.5M | Buy |
272,746
+1,643
| +0.6% | +$321K | 0.11% | 216 |
|
|
2021
Q2 | $54.6M | Buy |
271,103
+7,140
| +3% | +$1.49M | 0.12% | 205 |
|
|
2021
Q1 | $56.9M | Sell |
263,963
-63,204
| -19% | -$13.9M | 0.13% | 205 |
|
|
2020
Q4 | $77.3M | Buy |
327,167
+78,637
| +32% | +$18M | 0.16% | 162 |
|
|
2020
Q3 | $67.6M | Buy |
248,530
+3,888
| +2% | +$1.07M | 0.15% | 160 |
|
|
2020
Q2 | $71M | Buy |
244,642
+34,547
| +16% | +$9.37M | 0.17% | 144 |
|
|
2020
Q1 | $50M | Buy |
210,095
+14,035
| +7% | +$3.22M | 0.15% | 161 |
|
|
2019
Q4 | $42.9M | Sell |
196,060
-311
| -0.2% | -$62.9K | 0.1% | 223 |
|
|
2019
Q3 | $32.8M | Sell |
196,371
-2,995
| -2% | -$530K | 0.08% | 278 |
|
|
2019
Q2 | $35.6M | Sell |
199,366
-42,783
| -18% | -$7.48M | 0.12% | 204 |
|
|
2019
Q1 | $44.2M | Sell |
242,149
-93,050
| -28% | -$17.2M | 0.16% | 133 |
|
|
2018
Q4 | $55.5M | Sell |
335,199
-5,624
| -2% | -$974K | 0.23% | 97 |
|
|
2018
Q3 | $65.7M | Sell |
340,823
-327,920
| -49% | -$58.4M | 0.23% | 100 |
|
|
2018
Q2 | $114M | Buy |
668,743
+5,577
| +0.8% | +$864K | 0.19% | 115 |
|
|
2018
Q1 | $108M | Buy |
663,166
+2,351
| +0.4% | +$384K | 0.19% | 119 |
|
|
2017
Q4 | $99M | Buy |
660,815
+425
| +0.1% | +$62.9K | 0.17% | 133 |
|
|
2017
Q3 | $100M | Buy |
660,390
+2,035
| +0.3% | +$306K | 0.19% | 128 |
|
|
2017
Q2 | $84.8M | Buy |
658,355
+635
| +0.1% | +$76.4K | 0.16% | 142 |
|
|
2017
Q1 | $71.9M | Sell |
657,720
-3,485
| -0.5% | -$307K | 0.14% | 163 |
|
|
2016
Q4 | $48.7M | Buy |
661,205
+156,647
| +31% | +$12.7M | 0.1% | 233 |
|
|
2016
Q3 | $44M | Buy |
504,558
+6,751
| +1% | +$638K | 0.09% | 262 |
|
|
2016
Q2 | $42.8M | Buy |
497,807
+16,317
| +3% | +$1.41M | 0.09% | 259 |
|
|
2016
Q1 | $38.3M | Buy |
481,490
+5,169
| +1% | +$468K | 0.09% | 268 |
|
|
2015
Q4 | $59.9M | Buy |
476,321
+2,027
| +0.4% | +$245K | 0.14% | 171 |
|
|
2015
Q3 | $49.4M | Buy |
474,294
+10,537
| +2% | +$1.35M | 0.12% | 199 |
|
|
2015
Q2 | $57.3M | Buy |
463,757
+8,962
| +2% | +$1.13M | 0.13% | 187 |
|
|
2015
Q1 | $53.7M | Buy |
454,795
+19,581
| +4% | +$2.35M | 0.12% | 204 |
|
|
2014
Q4 | $51.7M | Buy |
435,214
+12,557
| +3% | +$1.41M | 0.12% | 204 |
|
|
2014
Q3 | $47.5M | Sell |
422,657
-19,186
| -4% | -$1.83M | 0.12% | 209 |
|
|
2014
Q2 | $41.8M | Buy |
441,843
+3,003
| +0.7% | +$211K | 0.1% | 255 |
|
|
2014
Q1 | $31M | Buy |
438,840
+6,774
| +2% | +$536K | 0.08% | 311 |
|
|
2013
Q4 | $32.1M | Buy |
432,066
+12,446
| +3% | +$867K | 0.08% | 292 |
|
|
2013
Q3 | $31.8M | Buy |
419,620
+7,423
| +2% | +$591K | 0.08% | 278 |
|
|
2013
Q2 | $33M | Buy |
+412,197
| New | +$30.4M | 0.09% | 258 |
|
Other funds holding VRTX
Mitsubishi UFJ Trust & Banking's VRTX Position: Q2 2026 in Review
Mitsubishi UFJ Trust & Banking increased its Vertex Pharmaceuticals (VRTX) stake by 4.7% in Q2 2026, buying an estimated $3.51M and bringing the position to 174,812 shares worth $86.8M. The position accounts for 0.19% of the portfolio, ranked #113.
Mitsubishi UFJ Trust & Banking first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $114M in Q2 2018. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Mitsubishi UFJ Trust & Banking held 174,812 shares of Vertex Pharmaceuticals worth $86.8M as of Q2 2026.
- Mitsubishi UFJ Trust & Banking bought 7,909 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.51M.
- Vertex Pharmaceuticals made up 0.19% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #113 holding.
- Mitsubishi UFJ Trust & Banking first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Mitsubishi UFJ Trust & Banking's Vertex Pharmaceuticals position peaked at $114M in Q2 2018.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.